Insider Trading activities of Cephalon Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cephalon Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cephalon Inc since year 2005. Table 2 shows the detailed insider transactions of Cephalon Inc since 2005. The reporting company's ticker symbol is CEPH. The reporting company's CIK number is 873364.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $156,107,281.
The total value of stock option exercises since 2005 is $60,084,755.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Cephalon Inc (CEPH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-05 0 $0 20,000 $1,596,050 20,000 $1,279,600
2010-12 0 $0 154,000 $9,867,180 150,000 $7,668,750
2010-03 0 $0 121,122 $8,578,978 105,000 $5,395,850
2010-02 0 $0 40,000 $2,716,150 0 $0
2009-12 0 $0 0 $0 41,000 $1,132,625
2009-09 0 $0 650 $38,837 0 $0
2009-03 0 $0 10,000 $634,500 10,000 $111,870
2008-12 0 $0 38,920 $2,961,709 18,319 $894,883
2008-09 0 $0 63,652 $4,802,543 70,000 $551,250
2008-08 0 $0 149,162 $11,201,704 131,602 $6,199,771
2008-03 0 $0 18,495 $1,115,271 10,000 $123,749
2007-12 0 $0 287,831 $22,255,604 185,475 $8,524,339
2007-11 0 $0 120,255 $8,978,272 60,000 $630,000
2007-05 0 $0 44,184 $3,559,377 42,625 $1,951,758
2007-02 0 $0 105,655 $7,963,616 112,074 $5,345,716
2006-12 0 $0 36,411 $2,531,673 0 $0
2006-09 0 $0 5,000 $290,080 5,000 $64,375
2006-03 0 $0 196,000 $15,722,077 139,500 $6,921,300
2006-02 0 $0 660,659 $49,829,622 394,923 $13,288,919
2005-09 0 $0 2,500 $114,412 0 $0
2005-05 0 $0 30,373 $1,349,626 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Cephalon Inc insiders (CEPH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-05-09 Greenacre Martyn D (Director) Sale 10,000 79.72 797,150
2011-05-09 Greenacre Martyn D (Director) Option Ex 10,000 63.98 639,800
2011-05-06 Egan William P (Director) Sale 10,000 79.89 798,900
2011-05-06 Egan William P (Director) Option Ex 10,000 63.98 639,800
2010-12-10 Baldassano Valli F. (Exec. VP, Chief Compliance Officer) Sale 4,000 63.42 253,680
2010-12-08 Baldino Frank Jr (Chairman and CEO) Sale 150,000 64.09 9,613,500
2010-12-08 Baldino Frank Jr (Chairman and CEO) Option Ex 150,000 51.12 7,668,750
2010-03-12 Aragues Alain (Exec. V.P.,President of Europe) Sale 1,450 70.88 102,776
2010-03-10 Russell Lesley (Exec. V.P., Chief Medical Off.) Sale 10,000 71.57 715,699
2010-03-10 Russell Lesley (Exec. V.P., Chief Medical Off.) Option Ex 10,000 51.12 511,250
2010-03-10 Egan William P (Director) Sale 10,000 71.48 714,800
2010-03-10 Egan William P (Director) Option Ex 10,000 59.25 592,500
2010-03-08 Vaught Jeffry L (Exec. V.P., Chief Scientific) Sale 59,672 70.72 4,220,003
2010-03-08 Vaught Jeffry L (Exec. V.P., Chief Scientific) Option Ex 45,000 48.13 2,165,850
2010-03-05 Buchi J Kevin (Chief Operating Officer) Sale 30,000 70.64 2,119,200
2010-03-05 Buchi J Kevin (Chief Operating Officer) Option Ex 30,000 51.12 1,533,750
2010-03-02 Greenacre Martyn D (Director) Sale 10,000 70.65 706,500
2010-03-02 Greenacre Martyn D (Director) Option Ex 10,000 59.25 592,500
2010-02-26 Savini Carl A (EVP Chief Administrative Ofcr) Sale 25,000 67.93 1,698,250
2010-02-25 Grebow Peter E (Exec. V.P.,Worldwide Tech. Ops) Sale 15,000 67.86 1,017,900
2009-12-08 Baldino Frank Jr (Chairman and CEO) Option Ex 41,000 27.62 1,132,625
2009-09-21 Baldassano Valli F. (Exec. VP, Chief Compliance Officer) Sale 650 59.75 38,837
2009-03-02 Egan William P (Director) Sale 10,000 63.45 634,500
2009-03-02 Egan William P (Director) Option Ex 10,000 11.19 111,870
2008-12-22 Roche Robert P Jr (EVP, WW Pharm Ops) Sale 23,920 77.24 1,847,509
2008-12-22 Roche Robert P Jr (EVP, WW Pharm Ops) Option Ex 18,319 48.85 894,883
2008-12-03 Buchi J Kevin (EVP & CFO) Sale 15,000 74.28 1,114,200
2008-09-19 Baldino Frank Jr (Chairman and CEO) Sale 63,652 75.45 4,802,543
2008-09-19 Baldino Frank Jr (Chairman and CEO) Option Ex 70,000 7.88 551,250
2008-08-11 Russell Lesley (Exec. VP, WW Med & Reg Affairs) Sale 27,000 77.23 2,085,210
2008-08-11 Russell Lesley (Exec. VP, WW Med & Reg Affairs) Option Ex 27,000 54.84 1,480,545
2008-08-11 Roche Robert P Jr (Exec. VP, WW Pharm Ops) Sale 21,676 76.96 1,668,184
2008-08-11 Roche Robert P Jr (Exec. VP, WW Pharm Ops) Option Ex 21,676 49.11 1,064,573
2008-08-07 Vaught Jeffry L (Exec. VP, R&D) Sale 17,560 76.44 1,342,286
2008-08-04 Grebow Peter E (Exec. VP, WW Technical Ops.) Sale 62,926 73.59 4,630,724
2008-08-04 Grebow Peter E (Exec. VP, WW Technical Ops.) Option Ex 62,926 49.11 3,090,484
2008-08-04 Wilensky Gail R (Director) Sale 10,000 73.51 735,100
2008-08-04 Wilensky Gail R (Director) Option Ex 10,000 45.23 452,299
2008-08-01 Greenacre Martyn D (Director) Sale 10,000 74.02 740,200
2008-08-01 Greenacre Martyn D (Director) Option Ex 10,000 11.19 111,870
2008-03-07 Egan William P (Director) Sale 8,895 60.32 535,813
2008-03-07 Egan William P (Director) Option Ex 8,895 12.38 110,075
2008-03-06 Egan William P (Director) Sale 1,105 61.36 67,805
2008-03-06 Egan William P (Director) Option Ex 1,105 12.38 13,674
2007-12-21 Roche Robert P Jr (Exec. VP, WW Pharm Ops.) Sale 7,185 72.62 521,745
2007-12-12 Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) Sale 34,176 75.94 2,593,076
2007-12-12 Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) Option Ex 34,176 49.63 1,696,052
2007-12-10 Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) Sale 1,347 78.56 105,813
2007-12-10 Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) Option Ex 2,074 48.20 99,966
2007-12-10 Savini Carl A (Exec. VP & CAO) Sale 61,043 78.67 4,801,101
2007-12-10 Savini Carl A (Exec. VP & CAO) Option Ex 50,125 49.63 2,487,553
2007-12-06 Russell Lesley (Exec. VP, WW Med & Reg Affairs) Sale 24,100 77.00 1,855,700
2007-12-06 Russell Lesley (Exec. VP, WW Med & Reg Affairs) Option Ex 24,100 47.61 1,147,473
2007-12-06 Buchi J Kevin (Exec. Vice President & CFO) Sale 20,000 76.00 1,520,060
2007-12-06 Vaught Jeffry L (Exec. VP & Pres., R&D) Sale 70,000 77.07 5,394,760
2007-12-06 Vaught Jeffry L (Exec. VP & Pres., R&D) Option Ex 70,000 43.31 3,031,420
2007-12-03 Greenacre Martyn D (Director) Sale 5,000 74.86 374,325
2007-12-03 Greenacre Martyn D (Director) Option Ex 5,000 12.38 61,875
2007-11-29 Grebow Peter E (Exec. VP, WW Technical Ops.) Sale 11,639 74.80 870,597
2007-11-28 Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) Sale 5,255 75.35 395,943
2007-11-19 Baldino Frank Jr (Chairman & CEO) Sale 52,552 74.83 3,921,279
2007-11-19 Baldino Frank Jr (Chairman & CEO) Option Ex 60,000 10.50 630,000
2007-05-30 Greenacre Martyn D (Director) Sale 5,000 81.43 407,150
2007-05-30 Greenacre Martyn D (Director) Option Ex 5,000 12.38 61,875
2007-05-25 Osborn John E (Exec VP, General Counsel & Sec) Sale 26,375 80.24 2,116,250
2007-05-25 Osborn John E (Exec VP, General Counsel & Sec) Option Ex 26,375 51.12 1,348,421
2007-05-09 Russell Lesley (Exec. VP, WW Med & Reg Affairs) Sale 1,559 80.00 124,727
2007-05-07 Osborn John E (Exec VP, General Counsel & Sec) Sale 11,250 81.00 911,250
2007-05-07 Osborn John E (Exec VP, General Counsel & Sec) Option Ex 11,250 48.13 541,462
2007-02-20 Grebow Peter E (Exec VP,Worldwide Tech Ops.) Sale 6,000 74.27 445,620
2007-02-16 Grebow Peter E (Exec VP,Worldwide Tech Ops.) Sale 50,000 75.37 3,772,365
2007-02-16 Grebow Peter E (Exec VP,Worldwide Tech Ops.) Option Ex 52,074 49.68 2,658,466
2007-02-16 Egan William P (Director) Sale 10,000 75.15 751,520
2007-02-16 Egan William P (Director) Option Ex 10,000 12.88 128,750
2006-12-22 Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) Sale 3,385 69.75 236,103
2006-12-22 Baldino Frank Jr (Chairman & CEO) Sale 20,000 69.25 1,385,000
2006-12-21 Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) Sale 5,000 69.75 348,750
2006-12-21 Osborn John E (Exec. VP & General Counsel) Sale 8,026 70.00 561,820
2006-09-05 Greenacre Martyn D (Director) Sale 5,000 58.02 290,080
2006-09-05 Greenacre Martyn D (Director) Option Ex 5,000 12.88 64,375
2006-03-01 Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) Sale 80,500 80.22 6,458,112
2006-03-01 Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) Option Ex 80,500 50.13 4,035,787
2006-03-01 Savini Carl A (Exec VP & Chief Admin Officer) Sale 59,000 80.22 4,732,270
2006-03-01 Savini Carl A (Exec VP & Chief Admin Officer) Option Ex 59,000 48.91 2,885,513
2006-02-27 Baldino Frank Jr (Chairman & CEO) Sale 103,098 80.45 8,294,234
2006-02-27 Baldino Frank Jr (Chairman & CEO) Option Ex 50,000 17.75 887,500
2006-02-24 Grebow Peter E (Exec VP,Worldwide Tech Ops.) Sale 45,000 76.58 3,446,183
2006-02-24 Grebow Peter E (Exec VP,Worldwide Tech Ops.) Option Ex 35,000 43.29 1,515,185
2006-02-21 Witzel Horst (Director) Sale 60,000 74.12 4,447,440
2006-02-21 Witzel Horst (Director) Option Ex 60,000 54.29 3,257,160
2006-02-21 Osborn John E (Sr. VP, General Counsel & Sec.) Sale 41,625 73.98 3,083,354
2006-02-21 Osborn John E (Sr. VP, General Counsel & Sec.) Option Ex 41,625 51.17 2,129,951
2006-02-21 Egan William P (Director) Sale 10,000 74.00 740,050
2006-02-17 Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) Sale 30,550 74.09 2,263,449
2006-02-17 Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) Option Ex 23,700 15.33 363,392
2006-02-17 Greenacre Martyn D (Director) Sale 15,000 74.44 1,116,675
2006-02-17 Greenacre Martyn D (Director) Option Ex 15,000 21.69 325,305
2006-02-17 Buchi J Kevin (Sr. Vice President and CFO) Sale 57,757 74.40 4,297,207
2006-02-17 Buchi J Kevin (Sr. Vice President and CFO) Option Ex 29,073 15.33 445,776
2006-02-17 Grebow Peter E (Exec VP,Worldwide Tech Ops.) Sale 10,000 73.33 733,340
2006-02-17 Grebow Peter E (Exec VP,Worldwide Tech Ops.) Option Ex 6,000 17.75 106,500
2006-02-17 Savini Carl A (Sr VP & Chief Admin Officer) Sale 49,185 73.93 3,636,050
2006-02-17 Savini Carl A (Sr VP & Chief Admin Officer) Option Ex 39,125 29.12 1,139,515
2006-02-17 Osborn John E (Sr. VP, General Counsel & Sec.) Sale 52,318 73.86 3,869,646
2006-02-17 Osborn John E (Sr. VP, General Counsel & Sec.) Option Ex 47,500 49.63 2,357,282
2006-02-17 Vaught Jeffry L (Sr. Vice Pres., and Pres., R&D) Sale 37,900 74.44 2,821,427
2006-02-17 Vaught Jeffry L (Sr. Vice Pres., and Pres., R&D) Option Ex 37,900 12.04 456,353
2006-02-17 Blake Paul (Exec VP, Clin Res & Reg Aff) Sale 6,938 74.53 517,075
2006-02-17 Egan William P (Director) Option Ex 10,000 30.50 305,000
2005-09-19 Roche Robert P Jr (Exec VP, Worldwide P) Sale 2,500 45.76 114,412
2005-05-17 Baldino Frank Jr (CEO) Sale 25,373 44.23 1,122,146
2005-05-09 Egan William P (Director) Sale 5,000 45.50 227,480

Insider trading activities including stock purchases, stock sales, and option exercises of CEPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cephalon Inc (symbol CEPH, CIK number 873364) see the Securities and Exchange Commission (SEC) website.